| abstract |
Use of a compound in the manufacture of a medicament for the treatment of cancer in a patient or subject in need thereof, said compound being according to the structure: in which X is H or F; R1 and R2 are independently H, an acyl group, an ether or C1-C20 alkyl group, a phosphate, diphosphate, triphosphate or phosphodiester group, or a pharmaceutically acceptable salt thereof, wherein said cancer is stomach, colon cancer. , rectal, pancreatic, lung, breast, cervix, uterine, ovarian, prostate, testis, bladder, renal, brain / CNS, head and neck, throat, Hodgkin's disease, non-Hodgkin lymphoma, multiple myeloma, leukemia, melanoma, Ewing's sarcoma, small cell lung cancer, choriocarcinoma, rhabdomyosarcoma, Wilm tumor, neuroblastoma, hair cell leukemia, mouth / pharynx, esophagus, larynx, kidney and lymphoma, characterized in that said compound is combined with an additional anticancer agent. |